P37 | Bulevirtide treatment for chronic HDV hepatitis: single-center experience: N. Capoluongo1, A. Izzi1, L. Fontanella2, G. D’Adamo3, A. Solano4, N. Cuomo5, A. Perrella1 | 1UOC of Emerging and Highly Contagious Infectious Diseases, Cotugno Hospital, Naples, 2Cardiovascular and Metabolic Internal Medicine, Monaldi Hospital, Naples, 3UOC Internal Medicine, Umberto I Hospital, Nocera Inferiore (SA), 4UOC Internal Medicine, Pellegrini Hospital, Naples, 5UOC Clinic Pathology, Cotugno Hospital, Naples, Italy. Italian Journal of Medicine, [S. l.], v. 19, n. 1(s1), 2025. DOI: 10.4081/itjm.2025.2229. Disponível em: https://www.italjmed.org/ijm/article/view/2229. Acesso em: 31 aug. 2025.